Final Version definition

Final Version means a non-copy protected and unencrypted digital master of the final version of the Web Site, recorded in executable form on the specified medium with any necessary supporting software and data, as to which all development work hereunder has been completed and which meets all requirements of the Statement of Work.
Final Version means the Beta Version of Publisher’s Directory that has been fully tested, modified, and accepted by Publisher for use on the World Wide Web.
Final Version means the final version of the Production in which agreed factual content and cohesive functions are included and any notices made by the Customer have been corrected and tested by the Producer at Milestone Deliveries.

Examples of Final Version in a sentence

  • Draft Version and Final Version of Final Report: A draft version of the Final Report shall be submitted to NYSERDA's Project Manager no later than the date specified in the Milestone Schedule of the NYSERDA Agreement for this task.

  • For text of the statement, see Cyprus Mail, “Joint Declaration Final Version as Agreed Between the Two Leaders,” February 11, 2014.

  • Bennett, “China Language Softened In Final Version Of QDR,” Defense News, February 7, 2010: 8.

  • There was the payments of 3,493 thousand yen for the purchase of property, plant and equipment to support our facilities and basic affiliated medical institutions.Cash Flow from Financing ActivitiesNet cash provided by financing activities totaled 37,749 thousand yen, compared with net cash used of 7,850 thousand yen in the same period of the previous fiscal year.

  • Final Version (H.R. 6523/P.L. 111-383)Section 1022 of H.R. 6523/P.L. 111-383 of January 7, 2011, expresses the sense of Congress that the Navy should name a combat ship for Father Vincent Capodanno, a lieutenant in the Navy Chaplain Corps.

  • Control Points and Compliance Criteria Integrated Farm Assurance – Comparison Version 3 to Final Version 4: All Farm Base [Online].

  • See “Modernizing the Regulatory System for Biotechnology Products: Final Version of the 2017 Update to the Coordinated Framework for the Regulation of Biotechnology,” January 2017, at 2017_coordinated_framework_update.pdf.

  • Annual Program Update Template Final Version: Approved PCCD May 20, 2016Introduction, Directions and Timeline The Peralta Community College District has an institutional effectiveness process which consists of the following components: a District-wide Strategic Plan which is updated every six years; Comprehensive Program Reviews which are completed every three years; and Annual Program Updates (APUs) which are completed in non-program review years.

  • Modernizing the Regulatory System for Biotechnology Products: Final Version of the 2017 Update to the Coordinated Framework for the Regulation of Biotechnology.

  • The contractor shall revise the draft deliverable based on the comments provided by the COR and then deliver a revised version of the deliverable, which will then be considered the Final Version.

More Definitions of Final Version

Final Version means the version of the Production after post production, which version will be delivered for use to the Client. General Terms and
Final Version means the version of the Project submitted to Customer for final approval.
Final Version. Once The Companies has reviewed the drafts and provided us its comments, we will prepare and deliver the final versions of the transfer pricing reports, and the opinion letters. As a result of our work we will issue opinions which will be based on the current applicable Mexican regulations in force. Such regulations may be modified or abrogated at any moment. As a result, such changes may affect the future validity of our conclusions, which would be updated in the event that The Companies requests it from us, causing additional fees. Our comments will not constitute a resolution of mandatory application. Thus, third parties may not agree with them.
Final Version means a non-copy protected and unencrypted disk master of a Product, recorded in executable object code form according to the agreed upon specifications attached hereto as Exhibit C (the "Specifications") with any necessary supporting software and data and which Broderbund accepts as conforming in all material respects to the Specifications and is completely debugged and tested. All Final Versions shall contain an updated privacy policy in the End User License Agreement, which allows Licensor to share end user data with Broderbund (the "End User Data").
Final Version. 3rd February, 2017 Your de-identified personal information (that is information that does not readily identify an individual) may be used by the healthcare provider for management of PEPs, research and statistical purposes. The healthcare provider will ensure that data will: x be protected, x not be provided to unauthorised third parties, x only be used for the stated purposes, and x remain de-identified. Your personal information will only be used or disclosed for the primary purpose for which it is collected. Personal information will be managed in accordance with the Personal Information Protection Act 2004, and the UTAS Personal Information Privacy Policy. For more information on how your information is being used ďLJ ƚŚĞ hŶŝǀĞƌƐŝƚLJ͕ Žƌ ƚŽ ĂĐĐĞƐƐ LJŽƵƌ ƉĞƌƐŽŶĂů ŝŶĨŽ xxxx://, or contact the University on (00) 0000 0000. The University may be required to provide your name, course information, healthcare provider details and your start and end date to the commonwealth government. The information is required for funding purposes and failure to consent to that information transfer will result in you not being permitted to undertake PEP. Further information will be provided to you via email when the data collection commences including the Privacy Policy for the commonwealth government and a contact person.
Final Version means the final version of the Work Product accepted pursuant to Section 1.8

Related to Final Version

  • Distribution Protocol means the plan for distributing the Settlement Amount and accrued interest, in whole or in part, as approved by the Courts.

  • Clinical evaluation means a systematic and planned process to continuously generate, collect, analyse and assess the clinical data pertaining to a device in order to verify the safety and performance, including clinical benefits, of the device when used as intended by the manufacturer;

  • Three-dimensional reference system means a system as described in Appendix 2 to this annex;

  • Component System means, as of its relevant License Effective Date, each Listed System and each Support Function that is part of the Licensed System and, subsequent to a relevant License Effective Date, such Listed Systems and Support Functions as they may be changed as provided in subsection (b) of the definition of Licensed System.

  • Distribution Network means a 'distribution network' as defined in Special Condition E2A of the Transporter's Licence held by each DN Operator;

  • Final Reference Pricei means the official closing price of the Underlyingi on the Determination Date;

  • Final Reference Price means an amount (which shall be deemed to be a monetary value in the Underlying Currency) equal to the level of the Index at the Valuation Time on the Valuation Date or the Issuer Call Date, as the case may be, as determined by or on behalf of the Calculation Agent without regard to any subsequently published correction or (if, in the determination of the Calculation Agent, no such level can be determined and no Market Disruption Event has occurred and is continuing) an amount determined by the Calculation Agent as its good faith estimate of the level of the Index on such date having regard to the then prevailing market conditions, the last reported trading price of the Shares and such other factors as the Calculation Agent determines relevant;

  • LOCKHEED XXXXXX Procurement Representative means a person authorized by LOCKHEED XXXXXX'x cognizant procurement organization to administer and/or execute this Contract.

  • Phase I Clinical Trial means a study in humans which provides for the first introduction into humans of a product, conducted in normal volunteers or patients to generate information on product safety, tolerability, pharmacological activity or pharmacokinetics, or otherwise consistent with the requirements of U.S. 21 C.F.R. §312.21(a) or its foreign equivalents.

  • Adjustment system means the device by which the seat or its parts can be adjusted to a position suited to the morphology of the seated occupant. This device may, in particular, permit:

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Double check valve assembly means an assembly composed of two single, independently acting, check valves including tightly closing shutoff valves located at each end of the assembly and suitable connections for testing the water tightness of each check valve.

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.

  • Data Universal Number System (DUNS) Number means the 9-digit number assigned by Dun and Bradstreet, Inc. (D&B) to identify unique business entities.

  • Diagnostic clinical procedures manual means a collection of written procedures that describes each method (and other instructions and precautions) by which the licensee performs diagnostic clinical procedures; where each diagnostic clinical procedure has been approved by the authorized user and includes the radiopharmaceutical, dosage, and route of administration.

  • Clinical nurse specialist means a registered nurse with relevant post-basic qualifications and 12 months’ experience working in the clinical area of his/her specified post-basic qualification, or a minimum of four years’ post-basic registration experience, including three years’ experience in the relevant specialist field and who satisfies the local criteria.

  • Nodal Reference Price at each location shall mean the 97th percentile price differential between day-ahead and real-time prices experienced over the corresponding two-month reference period in the prior calendar year. Reference periods will be Jan-Feb, Mar-Apr, May- Jun, Jul-Aug, Sept-Oct, Nov-Dec. For any given current-year month, the reference period months will be the set of two months in the prior calendar year that include the month corresponding to the current month. For example, July and August 2003 would each use July- August 2002 as their reference period. No-load Cost:

  • Distribution Network Operator or “DSO” shall mean the operator of a Distribution Network.

  • Subject of a Clinical Trial means the health care service, item, or drug that is being evaluated in the Approved Clinical Trial and that is not a Routine Patient Cost.

  • Distribution System means the system of wires and associated facilities between the delivery points on the transmission lines or the generating station connection and the point of connection to the installation of the consumers;

  • clinical evidence means clinical data and clinical evaluation results pertaining to a device of a sufficient amount and quality to allow a qualified assessment of whether the device is safe and achieves the intended clinical benefit(s), when used as intended by the manufacturer;

  • NERC Interchange Distribution Calculator means the NERC mechanism that is in effect and being used to calculate the distribution of energy, over specific transmission interfaces, from energy transactions.

  • Main Distribution Frame (MDF means the termination frame for outside facility and inter-exchange office equipment at the CO.

  • Phase III Clinical Trial means a large, controlled or uncontrolled Clinical Study that would satisfy the requirements of 21 CFR 312.21(c), intended to gather the additional information about effectiveness and safety that is needed to evaluate the overall benefit-risk relationship of the drug and to provide an adequate basis for physician labeling.

  • Participating Certified Clinical Nurse Specialist means a Certified Clinical Nurse Specialist who has a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan to provide services to you at the time services are rendered.

  • Phase IV Clinical Trial means a product support clinical trial of a Product commenced after receipt of Regulatory Approval in the country where such trial is conducted. A Phase IV Clinical Trial may include epidemiological studies, modeling and pharmacoeconomic studies, and investigator-sponsored clinical trials studying Product that are approved by BMS and that otherwise fit the foregoing definition.